Cosmetics & Personal Care | Monthly bulletin | April 2024
Navigating Aesthetic Procedures: Ensuring Compliance and Clinical Trials
The aesthetic industry is experiencing robust global growth, with projections indicating further expansion driven by rising interest in innovative approaches to dermatological aesthetics. Emerging trends encompass a range of scientifically advanced cosmeceutical skincare products, along with both invasive and non-invasive treatment modalities spanning physical, chemical, and pharmacological interventions. Additionally, holistic solutions integrating diverse methods and therapies are gaining traction. Regulatory agencies worldwide are implementing new frameworks to define and assess safety and efficacy parameters more clearly, while also combating malpractice and unregulated utilisation of aesthetic procedures. Consequently, there is a notable uptake in demand for clinical trials within this domain.
Eurofins Cosmetics & Personal Care is here to support you in the management of aesthetic studies involving medical devices and pharmaceutical products, whether conducted as single-centre or multi-centre studies:
- Standardised and validated imaging systems
- Quantitative analysis of skin surface features on 2D images
- Quantitative volume analysis on 3D images
- Clinical scorings and use of well-established scales
- Central quality control and scoring of images by experts or expert panels
- Patient satisfaction assessments using validated and/or custom questionnaires
- Biophysical measurement methods
Thanks to its network of dermatology experts and opinion leaders in the aesthetics field, Eurofins C&PC is able to identify and manage qualified sites and recruit patients in a timely manner, enabling it to deliver high-quality results.
Eurofins C&PC (EU, US, China) provides expertise in the conduct of Phase I to IV studies for pharmaceuticals, as well as compliance assessment investigations and post-marketing clinical follow-up (EU MDR) for medical devices.
Benzene in Acne Products: Guaranteeing Safety with Testing and Stability Studies
Benzene, identified as a human carcinogen by the World Health Organization (WHO), the International Agency for Research on Cancer (IARC), and the U.S. Centers for Disease Control and Prevention (CDC), poses significant health risks through various exposure routes such as inhalation, skin absorption, ingestion, and contact with skin or eyes.
Recent reports have highlighted high levels of benzene found in benzoyl peroxide (BPO)-containing acne products. In addition to contamination, benzene can form in BPO acne treatments due to the drug's degradation.
Benzene formation in BPO products poses a significant risk to consumer health. Stability testing conducted at elevated temperatures can unveil substantial benzene levels in multiple BPO products.
Eurofins Cosmetics and Personal Care is here to help you combat benzene contamination and ensure the safety of your products. We support efforts to combat benzene formation and ensure consumer safety. As such, we offer comprehensive benzene contamination testing services and perform accelerated stability studies to assess the risk of benzene formation in your benzoyl peroxide (BPO) products.
Mastering Cosmetic Packaging: The new CosPaTox Guide for Testing and the Interpretation of results
CosPaTox, a consortium focused on the intersection of Cosmetics, Packaging, and Toxicology, has just formulated a standardised, voluntary safety evaluation guidance for the use of plastic Post-Consumer Recyclates (PCR) in cosmetic product and detergent packaging.
The CosPaTox Consortium has undertaken extensive analytical testing as well as toxicological evaluation to understand the safety profile of PCR plastic materials made from PE, PP and LDPE which are used as packaging materials for cosmetic products, detergents, and home care products. Clear guidance to enable a holistic testing strategy as well as a safety assessment approach for recycled plastics has been developed, including the definition of three distinct quality levels for plastic recyclates. The CosPaTox Consortium’s approach to enable a robust safety assessment is technology neutral and does not consider or require any specific collection, sorting, or recycling technology. The focus is solely on the quality of the recycled materials themselves. The presented safety assessment approach can therefore be applied to any polyolefin recyclate, be it from a mechanical recycling, physical recycling, or chemical recycling origin.
By providing clear recommendations for the safe use of recycled plastic materials, even in the absence of food contact approvals, the CosPaTox Consortium’s work will help to boost the uptake of recycled materials in the packaging of cosmetic products and detergents and thereby contributing to a circular economy.
Eurofins Cosmetics & Personal Care, with a team of experts actively involved in CosPaTox, is committed to supporting you in understanding and obtaining the new dossier by contributing to strengthen the uptake of recycled materials in the packaging of your products.
What’s next?
Trade show
ASCC Annual Conference – 29th Apr - 1st May
Gold Coast – Stands 20 & 21
Suppliers’ Day - 1-2nd May
New York – Stand 1467
Live demo: Hair evaluation - May 1 – 1:00pm – Stand 1467
Roundtable: "Lunch & Learn - The Future of the Cosmetic Industry: Challenges & Opportunities" - May 1 from 12pm to 2:30pm - Meeting Room 1A03
Learn more: https://www.eurofins.com/cosmetics/media-centre/nyscc-suppliers-day/
Webinar
MoCRA Mastery: Navigating FDA Changes with Ease
21st May
Time: 10:00am EST / 05:00pm CET
Learn more: https://attendee.gotowebinar.com/register/72448359390787680?source=Monthly-Bulletin
Compléments alimentaires : Maitriser la conformité, la sécurité et l’efficacité
French Audience - 28th May
Time: 11:00am CET
Learn more: https://attendee.gotowebinar.com/register/6948946911618344542?source=Monthly-Bulletin
